CPHI [CHINA PHARMAS,] DEFR14C:
[]
CPHI [CHINA PHARMAS,] DEFR14C: (Original Filing)
[SCHEDULE 14C INFORMATION [ ] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
CPHI [CHINA PHARMAS,] DEFR14C: SCHEDULE 14C INFORMATION [ ] Preliminary Information Statement
[SCHEDULE 14C INFORMATION [ ] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
CPHI [CHINA PHARMAS,] DEF 14C: SCHEDULE 14C INFORMATION Amendment No. 1 [X] Preliminary
[SCHEDULE 14C INFORMATION Amendment No. 1 [X] Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction]
WX [WuXi PharmaTech (Cayman)] EFFECT: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
WX [WuXi PharmaTech (Cayman)] EFFECT: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
WX [WuXi PharmaTech (Cayman)] CORRESP: (Original Filing)
[WUXI PHARMATECH (CAYMAN) INC. 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI 200131 PEOPLES REPUBLIC OF CHINA September 21, 2009 VIA EDGAR AND FACSIMILE Mail Stop 4720 100 F Street N.E. Attention: Jeffrey P. Reidler, Assistant Director Scot Foley Re: WuXi PharmaTech (Cayman) Inc. Registration Statement on Form F-3 Filed September 4, 2009 File No. 333-161757 Dear Sirs: Please]
WX [WuXi PharmaTech (Cayman)] F-3/A: (Original Filing)
[] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Amendment No. 1 to Registration Statement No. 333-161757 on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.s internal control over financial]
WX [WuXi PharmaTech (Cayman)] F-3/A:
[] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Amendment No. 1 to Registration Statement No. 333-161757 on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.s internal control over financial]
